Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1346

The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive.
The rare endocrine disease treatment market is expected to grow rapidly over the forecast period owing to the increasing prevalence of rare endocrine diseases.
In 2018, the global Rare Endocrine Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Rare Endocrine Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rare Endocrine Disease Treatment development in United States, Europe and China.

The key players covered in this study
Novartis
Ipsen
Pfizer
Teva
EMD Serono
Novo Nordisk
Eli Lilly
Shire
Amgen
Corcept Therapeutics
Novelion Therapeutics

Market segment by Type, the product can be split into
Biologics
Organic Compounds

Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rare Endocrine Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Rare Endocrine Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rare Endocrine Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rare Endocrine Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Organic Compounds
1.5 Market by Application
1.5.1 Global Rare Endocrine Disease Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rare Endocrine Disease Treatment Market Size
2.2 Rare Endocrine Disease Treatment Growth Trends by Regions
2.2.1 Rare Endocrine Disease Treatment Market Size by Regions (2014-2025)
2.2.2 Rare Endocrine Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rare Endocrine Disease Treatment Market Size by Manufacturers
3.1.1 Global Rare Endocrine Disease Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Rare Endocrine Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rare Endocrine Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Rare Endocrine Disease Treatment Key Players Head office and Area Served
3.3 Key Players Rare Endocrine Disease Treatment Product/Solution/Service
3.4 Date of Enter into Rare Endocrine Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rare Endocrine Disease Treatment Market Size by Type (2014-2019)
4.2 Global Rare Endocrine Disease Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Rare Endocrine Disease Treatment Market Size (2014-2019)
5.2 Rare Endocrine Disease Treatment Key Players in United States
5.3 United States Rare Endocrine Disease Treatment Market Size by Type
5.4 United States Rare Endocrine Disease Treatment Market Size by Application

6 Europe
6.1 Europe Rare Endocrine Disease Treatment Market Size (2014-2019)
6.2 Rare Endocrine Disease Treatment Key Players in Europe
6.3 Europe Rare Endocrine Disease Treatment Market Size by Type
6.4 Europe Rare Endocrine Disease Treatment Market Size by Application

7 China
7.1 China Rare Endocrine Disease Treatment Market Size (2014-2019)
7.2 Rare Endocrine Disease Treatment Key Players in China
7.3 China Rare Endocrine Disease Treatment Market Size by Type
7.4 China Rare Endocrine Disease Treatment Market Size by Application

8 Japan
8.1 Japan Rare Endocrine Disease Treatment Market Size (2014-2019)
8.2 Rare Endocrine Disease Treatment Key Players in Japan
8.3 Japan Rare Endocrine Disease Treatment Market Size by Type
8.4 Japan Rare Endocrine Disease Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rare Endocrine Disease Treatment Market Size (2014-2019)
9.2 Rare Endocrine Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Rare Endocrine Disease Treatment Market Size by Type
9.4 Southeast Asia Rare Endocrine Disease Treatment Market Size by Application

10 India
10.1 India Rare Endocrine Disease Treatment Market Size (2014-2019)
10.2 Rare Endocrine Disease Treatment Key Players in India
10.3 India Rare Endocrine Disease Treatment Market Size by Type
10.4 India Rare Endocrine Disease Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Rare Endocrine Disease Treatment Market Size (2014-2019)
11.2 Rare Endocrine Disease Treatment Key Players in Central & South America
11.3 Central & South America Rare Endocrine Disease Treatment Market Size by Type
11.4 Central & South America Rare Endocrine Disease Treatment Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rare Endocrine Disease Treatment Introduction
12.1.4 Novartis Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Ipsen
12.2.1 Ipsen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rare Endocrine Disease Treatment Introduction
12.2.4 Ipsen Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.2.5 Ipsen Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rare Endocrine Disease Treatment Introduction
12.3.4 Pfizer Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Teva
12.4.1 Teva Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rare Endocrine Disease Treatment Introduction
12.4.4 Teva Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.4.5 Teva Recent Development
12.5 EMD Serono
12.5.1 EMD Serono Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rare Endocrine Disease Treatment Introduction
12.5.4 EMD Serono Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.5.5 EMD Serono Recent Development
12.6 Novo Nordisk
12.6.1 Novo Nordisk Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rare Endocrine Disease Treatment Introduction
12.6.4 Novo Nordisk Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.6.5 Novo Nordisk Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rare Endocrine Disease Treatment Introduction
12.7.4 Eli Lilly Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 Shire
12.8.1 Shire Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rare Endocrine Disease Treatment Introduction
12.8.4 Shire Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.8.5 Shire Recent Development
12.9 Amgen
12.9.1 Amgen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rare Endocrine Disease Treatment Introduction
12.9.4 Amgen Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.9.5 Amgen Recent Development
12.10 Corcept Therapeutics
12.10.1 Corcept Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rare Endocrine Disease Treatment Introduction
12.10.4 Corcept Therapeutics Revenue in Rare Endocrine Disease Treatment Business (2014-2019)
12.10.5 Corcept Therapeutics Recent Development
12.11 Novelion Therapeutics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details